iFabric Q4 Earnings Call Highlights

1 week ago 12

MarketBeat

Mon, April 13, 2026 astatine 10:43 AM CDT 8 min read

iFabric logo

iFabric logo
  • Record fiscal 2025 revenue of CAD 32.9 cardinal (+20%) but profitability weakened—gross borderline fell to 32% (Q4: 26%) and adjusted EBITDA dropped to CAD 1.9 million—mainly owed to tariffs and a impermanent intermission successful intimate-apparel shipments.

  • Q1 FY2026 guidance of CAD 25–27 cardinal is supported by an inventory physique to CAD 21 million, and absorption expects borderline betterment arsenic intimate apparel resumes nether iFabric’s ain brand, targeting blended gross margins of ~35–37% and adjusted EBITDA margins of ~15% successful 2026 (up to 20% successful 2027).

  • Strategic shifts and maturation initiatives: the institution ended the Maidenform licence to region royalties and grow merchandise flexibility, expanded its "Doctor’s Choice" scrubs to ~1,367 Walmart stores portion pursuing infirmary channels, diversified sourcing, and is lodging a ~USD 600,000 refund assertion for disputed tariffs.

  • Interested successful iFabric Corp.? Here are 5 stocks we similar better.

Executives astatine iFabric (TSE:IFA) highlighted grounds fiscal 2025 results and issued beardown first-quarter fiscal 2026 gross guidance during an capitalist call, portion besides addressing borderline headwinds tied to tariffs and a impermanent intermission successful intimate apparel shipments.

Giancarlo Beevis, COO of iFabric and CEO of its Intelligent Fabric Technologies unit, described the institution arsenic operating 2 divisions: Intelligent Fabric Technologies, which develops textile show chemistries and treatments (including antimicrobial protection, moisture management, cooling, and UV protection), and Coconut Grove Intimates, which distributes “solution-driven” intimate apparel and accessories done large retailers successful North America and prime markets successful Europe and the U.K.

→ Why PriceSmart’s Discount May Not Last Much Longer

Beevis said iFabric is aiming to bring its “proprietary technology, clinically proven technology” to marketplace by pairing treatments with finished products, describing the exemplary arsenic “chemistry to checkout.”

Chief Financial Officer Hilton Price said fiscal 2025 gross roseate to CAD 32.9 million from CAD 27.3 million successful the anterior year, a 20% increase and a institution record. Fourth-quarter gross was CAD 11.0 million, up from CAD 10.5 million a twelvemonth earlier.

→ 3 Surprising S&P 500 Outperformers of 2026

Price noted that Q4 gross would person been higher but for a shipping-timing contented tied to Costco’s gross designation terms. He said astir CAD 1 million of merchandise shipped successful precocious December arrived astatine lawsuit warehouses aft year-end, and due to the fact that Costco does not dainty hazard arsenic transferred until receipt astatine its warehouse, the gross shifted into Q1. Price said this timing contented was “one of the reasons wherefore we amended our guidance” for Q1.

Read Entire Article